Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans
2010 · Science · 1,994 citations
https://doi.org/10.1126/science.1193032
J
Jeffrey B. Kopp
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
599
Papers
40.9K
Citations
107
h-index
365
i10-index
Jeffrey B. Kopp is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Renal Diseases and Glomerulopathies & Chronic Kidney Disease and Diabetes & Renal and related cancers. The author has an h-index of 107, co-authored 510 publications.
ORCID: 0000-0001-9052-186XPapers by this author
worksPodocytopathies
2020 · Nature Reviews Disease Primers · 501 citations
https://doi.org/10.1038/s41572-020-0196-7
Innate immunity pathways regulate the nephropathy gene Apolipoprotein L1
2014 · Kidney International · 351 citations
https://doi.org/10.1038/ki.2014.270
Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
2016 · JCI Insight · 296 citations
https://doi.org/10.1172/jci.insight.88782
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy
2017 · Journal of Biological Chemistry · 295 citations
https://doi.org/10.1074/jbc.m117.779520
Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
2022 · Kidney International · 169 citations
https://doi.org/10.1016/j.kint.2022.03.019
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat